Author

M. D. Kalemera

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

J. Grove· 3 shared M. Palor· 2 shared A. Chumbe· 1 shared A. Underwood· 1 shared A.-K. Reuschl· 1 shared C. Forrest· 1 shared C. Jolly· 1 shared G. J. Towers· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

J. Grove

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintAug 10, 2022

Distantly related hepaciviruses share common entry factor, Claudin-1

K. Toon, M. D. Kalemera, M. Palor…·G. Mattiuzzo

This study identifies Claudin-1 as a shared entry factor for HCV and GBV-B, showing distinct mechanisms for each virus.

DOI 10.1101/2022.08.10.503556

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintMar 22, 2021

Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2

S. J. Dicken, M. J. Murray, L. G. Thorne…·J. Grove

This study characterizes the B.1.1.7 and Pangolin coronavirus spike proteins, revealing how NTD mutations enhance viral entry and provide insights into SARS-CoV-2 evolution.

DOI 10.1101/2021.03.22.436468

virusexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintJun 18, 2020

Optimised cell systems for the investigation ofhepatitis C virus E1E2 glycoproteins

M. D. Kalemera, J. Capella-Pujol, A. Chumbe…·J. Grove

This paper identifies an optimized cell line for producing HCV pseudoparticles and reveals antigenic differences between sE2 produced in 293T and 293F cells.

DOI 10.1101/2020.06.18.159442

proteomicsexperimental assay

𝕏 PostBluesky